Targeted Therapy for Chronic Lymphocytic Leukemia: A Glimpse Into the Future

被引：2
|
作者：
Hillmen, Peter [1 ]
机构：
[1] St Jamess Inst Oncol, Leeds, W Yorkshire, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
PHASE-I; SURVIVAL; BCL-2;
D O I：
10.1200/JCO.2011.37.8612
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：469 / 470
页数：2
相关论文
共 50 条
  • [31] Mechanisms of differential response to BTKi targeted therapy in patients with chronic lymphocytic leukemia
    Xu, Zhenshu
    Tang, Peixia
    Zhang, Wenjie
    Guo, Guangyao
    Long, Jinlan
    Lin, Jie
    Liu, Liping
    Chen, Xi
    LEUKEMIA & LYMPHOMA, 2023, 64 : S47 - S48
  • [32] Role of chemokines and their receptors in chronic lymphocytic leukemia Function in microenvironment and targeted therapy
    Han, Ting-Ting
    Fan, Lei
    Li, Jian-Yong
    Xu, Wei
    CANCER BIOLOGY & THERAPY, 2014, 15 (01) : 3 - 9
  • [33] Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada
    Lachaine, Jean
    Beauchemin, Catherine
    Guinan, Kimberly
    Thebault, Philippe
    Aw, Andrew
    Banerji, Versha
    Fleury, Isabelle
    Owen, Carolyn
    CURRENT ONCOLOGY, 2021, 28 (01) : 332 - 345
  • [34] The evolving role of time-limited targeted therapy in chronic lymphocytic leukemia
    Molica, Stefano
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (12) : 1015 - 1019
  • [35] Entering the Era of Targeted Therapy for Chronic Lymphocytic Leukemia: Impact on the Practicing Clinician
    Byrd, John C.
    Jones, Jeffrey J.
    Woyach, Jennifer A.
    Johnson, Amy J.
    Flynn, Joseph M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) : 3039 - 3047
  • [36] QUANTIFICATION OF EXPRESSION OF ANTIGENS TARGETED BY ANTIBODY BASED THERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Tembhare, Prashant R.
    Marti, Gerald
    Wiestner, Adrian
    Degheidy, Heba
    Farooqui, Mohammed
    Kreitman, Robert J.
    Jasper, Gregory A.
    Yuan, Constance M.
    Liewehr, David
    Venzon, David
    Stetler-Stevenson, Maryalice
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2012, 82B (05) : 340 - 340
  • [37] Targeted Drug Delivery for Chronic Lymphocytic Leukemia
    Makhloufi Zoulikha
    Wei He
    Pharmaceutical Research, 2022, 39 : 441 - 461
  • [38] Targeted Drug Delivery for Chronic Lymphocytic Leukemia
    Zoulikha, Makhloufi
    He, Wei
    PHARMACEUTICAL RESEARCH, 2022, 39 (03) : 441 - 461
  • [39] Sensitive monitoring of sequential targeted therapy resistance in relapsed/therapy refractory chronic lymphocytic leukemia
    Kotmayer, Lili
    Laszlo, Tamas
    Alpar, Donat
    Bodor, Csaba
    LEUKEMIA & LYMPHOMA, 2023, 64 : S193 - S194
  • [40] Bendamustine therapy in chronic lymphocytic leukemia
    Masiello, David
    Tulpule, Anil
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (10) : 1687 - 1698
12345